Mbandaka, DRC — The Democratic Republic of Congo (DRC) began administering an experimental Ebola vaccine to medical staff in the northwestern city of Mbandaka on Monday, to tackle an outbreak of the virus believed to have killed 26 people since early April. The World Health Organisation (WHO) hailed the vaccinations as a "paradigm shift" in how to fight the disease, which killed more than 11,300 people in a West African epidemic between 2013 and 2016. The WHO is sending 7,540 doses of the vaccine to the Central African country, 540 of which have been earmarked for Mbandaka, a city of about 1.5-million where four Ebola cases have been confirmed. In a ceremony attended by health minister Oly Ilunga Kalenga, health workers in blue overalls and rubber gloves administered the vaccine developed by US drug company Merck, marking the start of a complex effort to ring-fence the virus before it gets out of control. The other vaccines were due to be given to medical staff later on Monday at a ...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, Morningstar financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00.